annual FCF:
-$135.97M-$59.64M(-78.15%)Summary
- As of today (July 1, 2025), OCUL annual free cash flow is -$135.97 million, with the most recent change of -$59.64 million (-78.15%) on December 31, 2024.
- During the last 3 years, OCUL annual FCF has fallen by -$69.22 million (-103.71%).
- OCUL annual FCF is now -963.22% below its all-time high of -$12.79 million, reached on December 31, 2012.
Performance
OCUL Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$46.60M-$6.97M(-17.59%)Summary
- As of today (July 1, 2025), OCUL quarterly free cash flow is -$46.60 million, with the most recent change of -$6.97 million (-17.59%) on March 31, 2025.
- Over the past year, OCUL quarterly FCF has dropped by -$12.46 million (-36.50%).
- OCUL quarterly FCF is now -1474.99% below its all-time high of -$2.96 million, reached on September 30, 2013.
Performance
OCUL quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$148.43M-$12.46M(-9.17%)Summary
- As of today (July 1, 2025), OCUL TTM free cash flow is -$148.43 million, with the most recent change of -$12.46 million (-9.17%) on March 31, 2025.
- Over the past year, OCUL TTM FCF has dropped by -$61.32 million (-70.39%).
- OCUL TTM FCF is now -4268.07% below its all-time high of -$3.40 million, reached on March 31, 2013.
Performance
OCUL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
OCUL Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.2% | -36.5% | -70.4% |
| 3 y3 years | -103.7% | -146.9% | -117.9% |
| 5 y5 years | -70.3% | -144.0% | -100.4% |
OCUL Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -114.7% | at low | -483.2% | at low | -150.3% | at low |
| 5 y | 5-year | -150.0% | at low | -617.1% | at low | -181.1% | at low |
| alltime | all time | -963.2% | at low | -1475.0% | at low | -4268.1% | at low |
OCUL Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$46.60M(+17.6%) | -$148.43M(+9.2%) |
| Dec 2024 | -$135.97M(+78.1%) | -$39.63M(+8.1%) | -$135.97M(+14.0%) |
| Sep 2024 | - | -$36.65M(+43.5%) | -$119.25M(+31.6%) |
| Jun 2024 | - | -$25.54M(-25.2%) | -$90.59M(+4.0%) |
| Mar 2024 | - | -$34.14M(+49.0%) | -$87.11M(+14.1%) |
| Dec 2023 | -$76.32M(+20.5%) | -$22.91M(+186.7%) | -$76.32M(+5.2%) |
| Sep 2023 | - | -$7.99M(-63.8%) | -$72.52M(-7.6%) |
| Jun 2023 | - | -$22.07M(-5.5%) | -$78.49M(+15.8%) |
| Mar 2023 | - | -$23.35M(+22.2%) | -$67.79M(+7.1%) |
| Dec 2022 | -$63.32M(-5.1%) | -$19.11M(+36.8%) | -$63.32M(+5.5%) |
| Sep 2022 | - | -$13.96M(+22.8%) | -$59.99M(+1.2%) |
| Jun 2022 | - | -$11.37M(-39.8%) | -$59.29M(-12.9%) |
| Mar 2022 | - | -$18.88M(+19.6%) | -$68.10M(+2.0%) |
| Dec 2021 | -$66.74M(+22.7%) | -$15.78M(+19.1%) | -$66.74M(+16.2%) |
| Sep 2021 | - | -$13.26M(-34.3%) | -$57.46M(-1.1%) |
| Jun 2021 | - | -$20.18M(+15.2%) | -$58.07M(+10.0%) |
| Mar 2021 | - | -$17.52M(+169.5%) | -$52.81M(-2.9%) |
| Dec 2020 | -$54.40M(-31.8%) | -$6.50M(-53.2%) | -$54.40M(-20.0%) |
| Sep 2020 | - | -$13.87M(-7.0%) | -$67.96M(-8.2%) |
| Jun 2020 | - | -$14.92M(-21.9%) | -$74.06M(-6.0%) |
| Mar 2020 | - | -$19.10M(-4.8%) | -$78.81M(-1.3%) |
| Dec 2019 | -$79.82M(+56.1%) | -$20.07M(+0.5%) | -$79.82M(+8.0%) |
| Sep 2019 | - | -$19.96M(+1.5%) | -$73.88M(+13.2%) |
| Jun 2019 | - | -$19.67M(-2.2%) | -$65.26M(+11.8%) |
| Mar 2019 | - | -$20.11M(+42.4%) | -$58.37M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$51.12M(-13.0%) | -$14.13M(+24.5%) | -$51.12M(+6.6%) |
| Sep 2018 | - | -$11.35M(-11.3%) | -$47.94M(-9.6%) |
| Jun 2018 | - | -$12.79M(-0.5%) | -$53.01M(-4.2%) |
| Mar 2018 | - | -$12.85M(+17.4%) | -$55.35M(-5.8%) |
| Dec 2017 | -$58.73M(+63.5%) | -$10.95M(-33.3%) | -$58.73M(+4.7%) |
| Sep 2017 | - | -$16.42M(+8.5%) | -$56.07M(+17.2%) |
| Jun 2017 | - | -$15.13M(-6.8%) | -$47.85M(+11.9%) |
| Mar 2017 | - | -$16.23M(+95.7%) | -$42.77M(+19.1%) |
| Dec 2016 | -$35.92M(+1.1%) | -$8.29M(+1.1%) | -$35.92M(-2.2%) |
| Sep 2016 | - | -$8.20M(-18.4%) | -$36.74M(-4.1%) |
| Jun 2016 | - | -$10.04M(+7.1%) | -$38.31M(+1.7%) |
| Mar 2016 | - | -$9.38M(+3.0%) | -$37.67M(+6.1%) |
| Dec 2015 | -$35.52M(+63.3%) | -$9.11M(-6.8%) | -$35.52M(+9.4%) |
| Sep 2015 | - | -$9.78M(+4.0%) | -$32.48M(+10.8%) |
| Jun 2015 | - | -$9.40M(+30.0%) | -$29.31M(+18.8%) |
| Mar 2015 | - | -$7.23M(+19.2%) | -$24.67M(+13.4%) |
| Dec 2014 | -$21.76M(+66.9%) | -$6.07M(-8.2%) | -$21.76M(+12.4%) |
| Sep 2014 | - | -$6.61M(+38.8%) | -$19.35M(+23.2%) |
| Jun 2014 | - | -$4.76M(+10.1%) | -$15.70M(+12.5%) |
| Mar 2014 | - | -$4.32M(+18.0%) | -$13.96M(+7.1%) |
| Dec 2013 | -$13.03M(+1.9%) | -$3.66M(+23.8%) | -$13.03M(+39.1%) |
| Sep 2013 | - | -$2.96M(-1.8%) | -$9.37M(+46.2%) |
| Jun 2013 | - | -$3.01M(-11.4%) | -$6.41M(+88.6%) |
| Mar 2013 | - | -$3.40M | -$3.40M |
| Dec 2012 | -$12.79M | - | - |
FAQ
- What is Ocular Therapeutix annual free cash flow?
- What is the all time high annual FCF for Ocular Therapeutix?
- What is Ocular Therapeutix annual FCF year-on-year change?
- What is Ocular Therapeutix quarterly free cash flow?
- What is the all time high quarterly FCF for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly FCF year-on-year change?
- What is Ocular Therapeutix TTM free cash flow?
- What is the all time high TTM FCF for Ocular Therapeutix?
- What is Ocular Therapeutix TTM FCF year-on-year change?
What is Ocular Therapeutix annual free cash flow?
The current annual FCF of OCUL is -$135.97M
What is the all time high annual FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high annual free cash flow is -$12.79M
What is Ocular Therapeutix annual FCF year-on-year change?
Over the past year, OCUL annual free cash flow has changed by -$59.64M (-78.15%)
What is Ocular Therapeutix quarterly free cash flow?
The current quarterly FCF of OCUL is -$46.60M
What is the all time high quarterly FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly free cash flow is -$2.96M
What is Ocular Therapeutix quarterly FCF year-on-year change?
Over the past year, OCUL quarterly free cash flow has changed by -$12.46M (-36.50%)
What is Ocular Therapeutix TTM free cash flow?
The current TTM FCF of OCUL is -$148.43M
What is the all time high TTM FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM free cash flow is -$3.40M
What is Ocular Therapeutix TTM FCF year-on-year change?
Over the past year, OCUL TTM free cash flow has changed by -$61.32M (-70.39%)